ARB在心衰中治疗地位和临床应用.pptVIP

  • 9
  • 0
  • 约2.57万字
  • 约 29页
  • 2019-01-03 发布于浙江
  • 举报
* Framingham Heart Study investigators determined the lifetime risk (up to age 94 years) for developing overt HF at selected index ages in a 25-year follow-up of a population-based sample of men and women who were free of HF at baseline.1 At age 40 years, the lifetime risk for HF was 21% for men and 20% for women. Remaining lifetime risk did not change with advancing index age because of the rapidly increasing HF incidence rate: at age 80 years, the lifetime risk was 20% for men and 19% for women. Overall, when established clinical criteria are used to define overt HF, the lifetime ris

您可能关注的文档

文档评论(0)

1亿VIP精品文档

相关文档